large-scal office-bas studi use new class non-sed antihistamin report cen agent class antihistamin wide varieti famili practic patient phase IV prospect sequenc open-label design patient allerg rhiniti AR astemizol terfenadin result treatment group typic famili practic compar demograph sign symptom allerg rhiniti clinic profil group astemizol patient histori AR frequenc famili histori AR patient week analys frequenc sever sign symptom AR patient complaint group self-report improv qualiti life measur group differ treatment positive-r outcom final overal assess physician patient rate success therapi physician rate excel patient rate much astemizol physician rate good patient rate terfenadin 